Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes

Background: The efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in elderly patients with heart failure with preserved ejection fraction (HFpEF) remains unclear. Methods and Results: In a multicenter, controlled trial, the CANONICAL study, we enrolled 82 HFpEF (left ventricular ejection...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Tomoya, Kasama, Shu, Yamamoto, Masahiro, Nakano, Tomoya, Ueshima, Kazuhiro, Morikawa, Yoshinobu, Kawata, Hiroyuki, Yoshihisa, Akiomi, Nakayama, Masafumi, Komatsu, Sei, Soeda, Tsunenari, Watanabe, Makoto, Kawakami, Rika, Okada, Yasushi, Tanaka, Hiroyuki, Susuta, Yutaka, Kasahara, Masato, Tsujita, Kenichi, Takeishi, Yasuchika, Saito, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2021
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338435/
https://www.ncbi.nlm.nih.gov/pubmed/34414333
http://dx.doi.org/10.1253/circrep.CR-21-0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8338435/
https://www.ncbi.nlm.nih.gov/pubmed/34414333
http://dx.doi.org/10.1253/circrep.CR-21-0030

Ejemplares similares